Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03411031
Brief Title: Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide

First Submitted : January 19, 2018
First Submitted that Met QC Criteria : January 24, 2018
First Posted : January 25, 2018

Last Update Submitted that Met QC Criteria : December 30, 2019
Last Update Posted : January 2, 2020